Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Aronia melanocarpa, commonly known as black chokeberry, has garnered scientific interest for its potential role in supporting or mitigating arteriosclerosis (the thickening or hardening of the arteries). The primary basis for this is its exceptionally high content of polyphenols, particularly anthocyanins and proanthocyanidins, which have demonstrated antioxidant and anti-inflammatory properties in both in vitro and in vivo studies. Several small clinical trials and animal studies have reported that supplementation with Aronia berry extracts can reduce oxidative stress, lower blood pressure, and improve lipid profiles—all of which are significant risk factors for arteriosclerosis.

For example, a placebo-controlled clinical trial published in the journal Phytotherapy Research (2007) found that patients with metabolic syndrome who consumed Aronia extract for two months had significant improvements in total cholesterol, LDL cholesterol, and blood pressure compared to controls. Other in vivo studies have shown that Aronia supplementation can reduce markers of vascular inflammation and improve endothelial function in animal models of atherosclerosis.

Despite these promising findings, most studies to date are limited by small sample sizes, short durations, and variability in extract standardization. Larger, long-term clinical trials are needed to confirm the benefits and establish optimal dosing. Therefore, while there is scientific evidence supporting the use of Aronia melanocarpa for arteriosclerosis risk factors, it is not yet conclusive, and its use should be considered as potentially supportive rather than as a primary treatment.

More about Aronia melanocarpa
More about Arteriosclerosis

Other ingredients used for Arteriosclerosis

Other health conditions supported by Aronia melanocarpa

Products containing Aronia melanocarpa